---
title: Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread
description: Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread
image: https://www.amadorbioscience.com/hubfs/%F0%9F%9A%A8Publication%20Alert%F0%9F%9A%A8.jfif
---

![amador bioscience-png](https://www.amadorbioscience.com/hs-fs/hubfs/Web/logo/amador%20bioscience-png.png?width=166&height=64&name=amador%20bioscience-png.png)

- [Bioanalysis and Biomarker Services](https://www.amadorbioscience.com/bioanalysis-lab-solutions)
- [Clinical Pharmacology](https://www.amadorbioscience.com/clinical-pharmacology-services)
- [Regulatory Affairs](https://www.amadorbioscience.com/regulatory-affairs)
- [Clinical Research Services](https://www.amadorbioscience.com/clinical-research-services)
- [About Us](https://www.amadorbioscience.com/about-amador-bioscience) 
    - [About Amador](https://www.amadorbioscience.com/about-amador-bioscience)

- [News](https://www.amadorbioscience.com/news)
- [Resources](https://www.amadorbioscience.com/blog)
- [Amador China](https://www.amadorbio.cn)

# Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread

Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread

![Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread](https://www.amadorbioscience.com/hubfs/%F0%9F%9A%A8Publication%20Alert%F0%9F%9A%A8.jfif)\\

🚨Publication Alert🚨  
This week's publication is from Dr. [Nidal Al-Huniti](https://www.linkedin.com/in/ACoAAAD8YDcBJdazVfTujasz_jyYXTsScuXqx7c), President of Clinical Pharmacology at Amador Bioscience.

📃Read it here: [https://hubs.la/Q01vb2pl0](https://hubs.la/Q01vb2pl0)

The authors of this publication and others applied an agent-based mathematical model (ABM) to explore the role of anti-viral monoclonal antibodies (mAbs) in combination with vaccines in reducing the COVID-19 pandemic burden.

Mathematical modeling is a fast-growing tool to inform decision-making in scenarios where it may not be feasible to prospectively evaluate interventions in concert.

In this case, ABM was used to characterize the individual-level heterogeneity of SARS-CoV-2 transmission in the US population. The model enabled the simulation of various pandemic scenarios including vaccine and mAbs in combination with vaccine. The mAbs were used as active treatment for Treatment-as-Prevention strategy and as passive immunity for post-exposure prophylaxis (PEP).

The results indicated that the use of anti-viral mAbs as treatment and PEP in combination with a vaccination program would substantially reduce SARS-CoV-2 transmission and pandemic burden. This approach can inform public health policies and is applicable to future pandemic preparedness.

![未标题-1](https://www.amadorbioscience.com/hs-fs/hubfs/%E6%9C%AA%E6%A0%87%E9%A2%98-1.png?width=210&height=80&name=%E6%9C%AA%E6%A0%87%E9%A2%98-1.png)

- Contact 
    - [Email Us](mailto:CBS_contact@crystalpharmatech.com)
    - +1-609-604-8303
    - [Contact Us](https://www.amadorbioscience.com/contact-amador)
- Our Services 
    - [Bioanalysis and Biomarker Services](https://www.amadorbioscience.com/bioanalysis-lab-solutions)
    - [Clinical Pharmacology](https://www.amadorbioscience.com/clinical-pharmacology-services)
    - [Regulatory Affairs](https://www.amadorbioscience.com/regulatory-affairs)
    - [Clinical Research Services](https://www.amadorbioscience.com/clinical-research-services)
- Information 
    - [About Us](https://www.amadorbioscience.com/about-amador-bioscience)
    - [Careers](https://www.crystalpharmatech.com/careers/)
    - [Events](https://www.crystalpharmatech.com/events/)
    - [News](https://www.amadorbioscience.com/news)

- [Privacy Policy](https://www.amadorbioscience.com/privacy-policy)
- [Terms & Conditions](https://www.amadorbioscience.com/terms-conditions)

By signing up, you agree to the [Privacy Policy](https://www.amadorbioscience.com/privacy-policy).

Copyright © 2026 Amador Bioscience, All rights reserved

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Amador Bioscience",
    "url" : "https://www.amadorbioscience.com/blog/author/amador-bioscience"
  },
  "dateModified" : "2024-04-19T02:56:03.796Z",
  "datePublished" : "2022-12-14T10:42:00.000Z",
  "headline" : "Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread",
  "image" : [ "https://www.amadorbioscience.com/hubfs/%F0%9F%9A%A8Publication%20Alert%F0%9F%9A%A8.jfif" ],
  "mainEntityOfPage" : {
    "@id" : "https://www.amadorbioscience.com/blog/monoclonal-antibody-treatmentprophylaxis-and-vaccines-combined-to-reduce-sars-cov-2spread",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.amadorbioscience.com/hubfs/Horizontal%20Amador%20logo-EN%20(1).png"
    },
    "name" : "Amador Bioscience"
  }
}
```